A Phase 3, Controlled, Open-label, Global Randomized Study of RRx-001 With a Platinum Doublet or a Platinum Doublet in Small Cell Lung Cancer

Clinical trial NCT05566041 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05566041
Sponsor: EpicentRx, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Carcinoma, Small Cell Lung

Start date: 2022-08-01
Primary completion: 2025-12-31
Enrollment: 292

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.